Niche Focus Entegrion specializes in developing innovative medical devices and biological technologies that address unmet clinical needs with limited competition, indicating potential for tailored partnerships and niche market expansion.
Recent Product Launch The launch of the VCM Vet viscoelastic coagulation testing platform opens opportunities to collaborate with veterinary clinics, animal health organizations, and research institutions seeking advanced diagnostic tools.
Growth Potential With a revenue estimate between 10 and 25 million dollars and recent funding of 14 million, Entegrion demonstrates financial stability and growth prospects suitable for strategic investment and partnership opportunities.
Industry Positioning Operating in the competitive biotech research sphere alongside companies like Baxter and Abbott, Entegrion represents a specialized player, creating prospects for high-value, innovative product solutions targeting healthcare and veterinary markets.
Technological Edge Utilizing advanced cloud-based technologies and digital tools, Entegrion leverages reliable infrastructure for R&D and product development, presenting an opportunity to align with tech-savvy healthcare providers and research partners.
$10M$25M
$10B
$10B
$10B
$500M$1B
$10B
$10B
$100M$250M
$1B$10BEntegrion, Inc. uses 8 technology products and services including RSS, Cloudflare, oEmbed, and more. Explore Entegrion, Inc.'s tech stack below.
| Entegrion, Inc. Email Formats | Percentage |
| FLast@entegrion.com | 34% |
| First.Last@entegrion.com | 25% |
| Last@entegrion.com | 7% |
| FLast@entegrion.com | 34% |
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Entegrion identifies, invents and systematically develops device and biological technologies to meet clearly defined medical needs. Our pipeline is distinguished by its uniqueness--- we pursue areas with limited competition and profound needs. We design efficient and focused development plans to assure that the products we deliver perform as intended and are ready for market. Twitter @entegrioninfo
Company Overview
Funding & FinancialsEntegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.
Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsEntegrion, Inc. has raised a total of $14M of funding over 5 rounds. Their latest funding round was raised on Jul 05, 2022 in the amount of $14M.
Entegrion, Inc.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com